JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M610404200 on November 17, 2006

J. Biol. Chem., Vol. 282, Issue 2, 853-862, January 12, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
282/2/853    most recent
M610404200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Olave, I. A.
Right arrow Articles by Li, Q.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Olave, I. A.
Right arrow Articles by Li, Q.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Purification and Identification of Proteins That Bind to the Hereditary Persistence of Fetal Hemoglobin –198 Mutation in the {gamma}-Globin Gene Promoter*

Ivan A. Olave{ddagger}1, Catalin Doneanu§, Xiangdong Fang{ddagger}, George Stamatoyannopoulos{ddagger}, and Qiliang Li{ddagger}2

From the {ddagger}Department of Medicine, Division of Medical Genetics, and the §Mass Spectrometry Center, Department of Medicinal Chemistry, University of Washington, Seattle, Washington 98195

Expression of the {gamma}-globin gene is silenced in adult humans. However, certain point mutations in the {gamma}-globin gene promoter are capable of maintaining expression of this gene during adult erythropoiesis, a condition called non-deletion hereditary persistence of fetal hemoglobin (HPFH). Among these, the British form of HPFH carrying a T ->C point mutation at position –198 of the A{gamma}-globin gene promoter results in 4–10% fetal hemoglobin in heterozygotes. In this study, we used nuclear extracts from murine erythroleukemia cells to purify a protein complex that binds the HPFH –198 {gamma}-globin gene promoter. Members of this protein complex were identified by mass spectrometry and include DNMT1, the transcriptional coactivator p52, the protein SNEV, and RAP74 (the largest subunit of the general transcription factor IIF). Sp1, which was previously considered responsible for HPFH –198 {gamma}-globin gene activation, was not identified. The potential role of these proteins in the reactivation and/or maintenance of {gamma}-globin gene expression in the adult transcriptional environment is discussed.


Received for publication, November 8, 2006

* This work was supported by National Institutes of Health Grants DK61805 and HL73439 (to Q. L.) and Grant DK45365 (to G. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 Present address: Blue Heron Biotechnology, Inc., Bothell, WA 98021.

2 To whom correspondence should be addressed: Div. of Medical Genetics, University of Washington, P. O. Box 357720, Seattle, WA 98195. Tel.: 206-616-4526; Fax: 206-616-4527; E-mail: li111640{at}u.washington.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.